These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28201723)

  • 1. Agents with vasodilator properties in acute heart failure.
    Singh A; Laribi S; Teerlink JR; Mebazaa A
    Eur Heart J; 2017 Feb; 38(5):317-325. PubMed ID: 28201723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilators in acute heart failure - evidence based on new studies.
    Travessa AM; Menezes Falcão L
    Eur J Intern Med; 2018 May; 51():1-10. PubMed ID: 29482882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Treatment of Acute Heart Failure.
    Hsiao R; Greenberg B
    Prog Cardiovasc Dis; 2016; 58(4):367-78. PubMed ID: 26764279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing Hypertensive Acute Heart Failure Management with Afterload Reduction.
    Collins S; Martindale J
    Curr Hypertens Rep; 2018 Feb; 20(1):9. PubMed ID: 29478124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database.
    Gradman AH; Vekeman F; Eldar-Lissai A; Trahey A; Ong SH; Duh MS
    J Card Fail; 2014 Nov; 20(11):853-63. PubMed ID: 25152497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
    Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M
    Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of intravenous vasodilators in acute heart failure management.
    Piper S; McDonagh T
    Eur J Heart Fail; 2014 Aug; 16(8):827-34. PubMed ID: 25100108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilators in Acute Heart Failure: Review of the Latest Studies.
    Levy PD; Laribi S; Mebazaa A
    Curr Emerg Hosp Med Rep; 2014 Jun; 2(2):126-132. PubMed ID: 24855585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilators in acute heart failure.
    Hollenberg SM
    Heart Fail Rev; 2007 Jun; 12(2):143-7. PubMed ID: 17447137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serelaxin in acute heart failure: Most recent update on clinical and preclinical evidence.
    Ghosh RK; Banerjee K; Tummala R; Ball S; Ravakhah K; Gupta A
    Cardiovasc Ther; 2017 Feb; 35(1):55-63. PubMed ID: 27727514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel vasodilators in heart failure.
    Zamani P; Greenberg BH
    Curr Heart Fail Rep; 2013 Mar; 10(1):1-11. PubMed ID: 23299783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
    Kirk JD; Parissis JT; Filippatos G
    Heart Fail Clin; 2009 Jan; 5(1):43-54, vi. PubMed ID: 19026385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protection.
    Díez J; Ruilope LM
    Eur Heart J Cardiovasc Pharmacother; 2016 Apr; 2(2):119-30. PubMed ID: 27418970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.
    Sato N; Lam CS; Teerlink JR; Greenberg BH; Tsutsui H; Oh BH; Zhang J; Lefkowitz M; Hua TA; Holbro T; Marshood M; Wang XL; Ge J
    J Card Fail; 2017 Jan; 23(1):63-71. PubMed ID: 27825893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilators in the management of acute heart failure.
    Elkayam U; Janmohamed M; Habib M; Hatamizadeh P
    Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of vasodilators in acute decompensated heart failure: the old and the new.
    Carlson MD; Eckman PM
    J Card Fail; 2013 Jul; 19(7):478-93. PubMed ID: 23834924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies.
    Anker SD; Ponikowski P; Mitrovic V; Peacock WF; Filippatos G
    Eur Heart J; 2015 Mar; 36(12):715-23. PubMed ID: 25670819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of guanylate cyclase modulators in decompensated heart failure.
    Mitrovic V; Hernandez AF; Meyer M; Gheorghiade M
    Heart Fail Rev; 2009 Dec; 14(4):309-19. PubMed ID: 19568931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilator Therapies in the Treatment of Acute Heart Failure.
    Holt DB; Pang PS
    Curr Heart Fail Rep; 2019 Feb; 16(1):32-37. PubMed ID: 30762175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute heart failure: lessons learned so far.
    Howlett JG
    Can J Cardiol; 2011; 27(3):284-95. PubMed ID: 21601768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.